Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs

Journal of Clinical Investigation

Volumn 107, Issue 12, 2001, Pages 1591-1598

  Foster, C J ^a   Prosser, D M ^a   Agans, J M ^a   Zhai, Y ^a   Smith, M D ^a   Lachowicz, J E ^a   Zhang, F L ^a   Gustafson, E ^a   Monsma F J , Jr ^a   Wiekowski, M T ^a   Abbondanzo, S J ^a   Cook, D N ^a   Bayne, M L ^a   Lira, S A ^a   Chintala, M S ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE DIPHOSPHATE RECEPTOR; ADENYLATE CYCLASE; ANTICOAGULANT AGENT; CALCIUM ION; CLOPIDOGREL; COLLAGEN; PYRIDINE DERIVATIVE; THROMBIN; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLEEDING TIME; CALCIUM TRANSPORT; CELL SHAPE; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0034978187     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12242     Document Type: Article

References (29)

1. ADP receptors on platelets
2. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets
3. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation
4. Activation of ADP receptors and platelet function
5. Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates
6. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors
7. Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines
8. P2X1 purinoceptor in human platelets. Molecular cloning and functional characterization after heterologous expression
9. Role of P2Y1 purinoceptor in ADP-induced platelet activation
10. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells
11. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor
12. Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation
13. Decreased platelet aggregation, increased bleeding time, and resistance to thromboembolism in P2Y1-deficient mice
14. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice
15. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets
16. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel
17. Key role of the P2Y1 receptor in tissue factor-induced thrombin-dependent acute thromboembolism: Studies in P2Y1-knockout mice and mice treated with a P2Y1 antagonist
18. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase
19. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets
20. ADP receptors and clinical bleeding disorders
21. Specific impairment of human platelet P2Yac ADP receptor-mediated signaling by the antiplatelet drug clopidogrel
22. Ticlopidine and clopidogrel
23. ADP is the cognate ligand for the orphan G-protein coupled receptor SP1999
24. Platelet aggregation monitored in a 96 well microplate reader is useful for evaluation of platelet agonists and antagonists
25. P2Y1-receptors in human platelets which are pharmacologically distinct from P2YADP-receptors
26. Desensitization of the platelet aggregation response to ADP: Differential down-regulation of the P2Y1 and P2Ycyc receptors
27. Identification of the platelet ADP receptor targeted by antithrombotic drugs
28. ADP is not an agonist at P2X1 receptors: Evidence for separate receptors stimulated by ATP and ADP on human platelets
29. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin